Ascendis, BioMarin Reach Global YUVIWEL License Deal
COPENHAGEN, Denmark, August 31, 2026 Ascendis Pharma A/S and BioMarin Pharmaceutical Inc. have entered into a binding term sheet...
Mergers & Acquisitions for New Therapy
AstraZeneca Completes Global Zegfrovy License Deal
CAMBRIDGE, UK, Sept. 1, 2026 AstraZeneca announced the completion of its previously announced exclusive global license agreement with Dizal...
Lilly to Acquire Merida in $2.875B Immunology Deal
Indianapolis, Indiana, and Cambridge, Massachusetts, August 31, 2026 Eli Lilly and Company and Merida Biosciences, Inc. announced a definitive...
RedHill Divests Talicia to Apotex for $18 Million
Miami, Florida, August 31, 2026 RedHill Biopharma Ltd. announced that it has entered into an agreement to divest Talicia®...
Teva Bids for BioXcel’s BXCL501 in Potential At-Home Agitation Treatment Deal
Tel Aviv, Israel – August 28, 2026 Teva Pharmaceutical Industries announced that it has entered into an agreement to...
Samsung Biologics Plans KRW 3 Trillion Rights Offering
INCHEON, SOUTH KOREA, Aug 27, 2026 Samsung Biologics has announced plans for a KRW 3 trillion rights offering to...
DualityBio and Genentech Partner on Next-Gen ADCs
SHANGHAI, CHINA, Aug 28, 2026 Duality Biotherapeutics, Inc. (DualityBio) has entered into a global collaboration and license agreement with...
argenx Completes Forte Biosciences Acquisition for FB102
Amsterdam, the Netherlands – August 27, 2026 argenx announced the successful completion of its acquisition of Forte Biosciences, Inc.,...
Biohaven, SK Biopharmaceuticals Sign Global Opakalim Deal
NEW HAVEN, Conn. and SEOUL, South Korea, Aug. 26, 2026 Biohaven Ltd. and SK Biopharmaceuticals announced a strategic global...
Hanmi Pharm Licenses Obesity Drug HM17321 to Genentech
SEOUL, South Korea, August 24, 2026 Hanmi Pharm announced an exclusive global licensing agreement with Genentech, a member of...